Monitoring immunotherapy with serologically active glycolipid fractions of BCG.
D000912:Antibodies, Neoplasm / Q000032:analysis; D001500:BCG Vaccine; D006017:Glycolipids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008545:Melanoma / Q000188:drug therapy; D009163:Mycobacterium bovis
D000912:Antibodies, Neoplasm; D001500:BCG Vaccine; D006017:Glycolipids